Filing Details

Accession Number:
0001209191-10-061408
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-12-17 16:34:43
Reporting Period:
2010-12-15
Filing Date:
2010-12-17
Accepted Time:
2010-12-17 16:34:43
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1333170 Nxstage Medical Inc. NXTM Electromedical & Electrotherapeutic Apparatus (3845) 043454702
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1341403 Jr E Joseph Turk C/O Nxstage Medical, Inc.
439 South Union Street, 5Th Floor
Lawrence MA 01843
Svp Commercial Operations No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-12-15 2,613 $4.54 120,338 No 4 M Direct
Common Stock Acquisiton 2010-12-15 2,337 $2.11 122,675 No 4 M Direct
Common Stock Disposition 2010-12-15 4,950 $23.73 117,725 No 4 S Direct
Common Stock Disposition 2010-12-15 9,950 $23.72 107,775 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2010-12-15 2,613 $0.00 2,613 $4.54
Common Stock Stock Option (right to buy) Disposition 2010-12-15 2,337 $0.00 2,337 $2.11
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
35,349 2008-04-27 2015-03-26 No 4 M Direct
32,751 2009-04-05 2016-03-04 No 4 M Direct
Footnotes
  1. This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 12, 2010, and amended August 23, 2010.
  2. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $23.44 to $24.18. The reporting person undertakes to provide to the issuer, any holder of the issuer's stock, or the SEC, upon request, full information regarding the number of shares sold at each separate price within the range described above.
  3. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $23.44 to $24.18. The reporting person undertakes to provide to the issuer, any holder of the issuer's stock, or the SEC, upon request, full information regarding the number of shares sold at each separate price within the range described above.
  4. This option was granted on March 27, 2008 and vests over four years in equal monthly installments.
  5. This option was granted on March 5, 2009 and vests over three years in equal monthly installments.